Results 131 to 140 of about 8,073 (181)

Genetic Variants in Oxidative Stress-Related Genes and Their Impact on Prognosis and Treatment Response in Chronic Myeloid Leukemia Patients. [PDF]

Int J Mol Sci
Alves R, Ventura F, Jorge J, Marques G, Coucelo M, Diamond J, Oliveiros B, Pereira A, Freitas-Tavares P, Almeida AM, Gonçalves AC, Sarmento-Ribeiro AB.   +11 more
europepmc   +1 more source

Impact of national volume-based procurement policy on drugs treating chronic Myelogenous Leukemia. [PDF]

J Health Popul Nutr
Yang Z, Li Y, Liu S, Han X, Wu Y, Fan X, Li Y, Jiang B.   +7 more
europepmc   +1 more source

Subclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and chronic myeloid leukemia. [PDF]

Ann Hematol
Tran Quang V, Cretin J, Loyaux R, Ben Jedidia B, Tarfi S, Gricourt G, Barathon Q, Joy C, Etancelin P, Wagner-Ballon O, Pautas C, Roy L, Sloma I.   +12 more
europepmc   +1 more source

Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemia. [PDF]

Leukemia
Krizkova J, Polivkova V, Laznicka A, Curik N, Benesova A, Suchankova P, Smazik T, Vysinova V, Mikulenkova D, Klamova H, Markova MS, Srbova D, Zuna J, Zaliova M, Trka J, Salek C, Polakova KM.   +16 more
europepmc   +1 more source

Real-World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi-Resistant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patient Population. [PDF]

Hematol Oncol
Breccia M, Rossi AR, Giai V, Martino B, Fava C, Annunziata M, Abruzzese E, Binotto G, Baratè C, Nardozza AP, Misto A, Coco P, Calafiore V, Carraro MC, Cattina F, Cavazzini F, Corsetti MT, Crucitti L, Crugnola M, Di Veroli A, Ditonno P, Ermacora A, Ferrara F, Genua A, Gozzini A, Impera S, Iurlo A, Levato L, Luciano L, Miggiano MC, De Gobbi M, Santoro M, Scappini B, Scortechini AR, Patriarca A, Rosati S, Russo S, Sancetta R, Sanpaolo G, Santeramo TM, Sibilla S, Sorà F, Sportoletti P, Stagno F, Trabacchi E, Castagnetti F.   +45 more
europepmc   +1 more source

Chronic myelogenous leukemia secondary to colon cancer: A case report. [PDF]

World J Gastrointest Oncol
Li XL, Li M, Yang H, Tian J, Shi ZW, Wang LZ, Song K.   +6 more
europepmc   +1 more source

Phosphorylation-inducing chimera rewires oncogenic kinase to trigger apoptosis

Merz ML, Shoba VM, Pergu R, Severance ZC, Munkanatta Godage DNP, Deb A, Kwok HS, Singh P, Singh S, Allen JB, Tian W, Gosavi PM, Chaudhary SK, Anokhina V, Weisberg EL, Payne NC, He Y, Osadchey R, Shekhar M, Mazitschek R, Rees MG, Roth JA, Cui Q, Griffin JD, Liau BB, Choudhary A.   +25 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft

Experimental Hematology, 2000
An important step in successful autografting of patients with chronic myelogenous leukemia is the delivery of a leukemia-free graft. We conducted this study to determine whether the cytogenetic response after autografting was correlated with the number of BCR ABL-positive cells present within the stem cell grafts.By BCR-ABL mRNA quantification, we ...
Monica Abate, F Vassallo, Cristina Parodi, Silvia Luchetti, Giuseppina Li Pira, Fabrizio Manca, Giovanna Piaggio, Angelo Michele Carella, Marina Cavaliere, O. Figari, Enrica Lerma, A. Dejana, Maria Teresa Corsetti   +12 more
openaire   +3 more sources

Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker

Annals of Hematology, 2008
Assay of phosphotyrosine levels using flow cytometry has been used to identify patients with chronic myelogenous leukemia positive for the Bcr-Abl fusion gene. We hypothesized that clinical monitoring could identify treatment response through reductions in intragranulocyte phosphotyrosine.
Yong-gong Yang, Yu-Jie Wu, Junhao Chen, Xue-Mei Sun, Dong Li, Wei Xu, Wei Xie, Lei-lei Chen, Jianyong Li, Pengjun Jiang   +9 more
openaire   +3 more sources

Absence of the hybrid bcr‐abl mRNA in Ph¹‐positive B lymphoblastoid cell lines established from a patient with chronic myelogenous leukemia [PDF]

International Journal of Cancer, 1987
AbstractThe expression of c‐abl, c‐sis, c‐myc and N‐ras oncogenes was examined in 2 lymphoblastoid cell lines, one with Ph1 (PB‐1049) and the other without Ph1 (LN‐1049), both established from a patient with chronic myelogenous leukemia (CML), and in a Ph1‐positive cell line (PB‐1049‐T) derived from a tumor formed after transplantation of PB‐1049 cells
Tsuneyuki Oikawa, Toshiyuki Yamada, Noboru Kuzumaki, Motomichi Sasaki, Nobuo Takagi   +4 more
openaire   +2 more sources